| Literature DB >> 30574129 |
Xiaojing Tian1,2, Qianqian Yu1,2, Donghao Yao1,2, Lele Shao1,2, Zhihong Liang1,2, Fei Jia1,2, Xingmin Li1,2, Teng Hui1,2, Ruitong Dai1,2.
Abstract
The objective of this study was to investigate the effects of ohmic heating and water bath heating (WB) on the metabolome of Escherichia coli O157:H7 cells at the same inactivation levels. Compared to low voltage long time ohmic heating (5 V/cm, 8.50 min, LVLT) and WB (5.50 min), the high voltage short time ohmic heating (10 V/cm, 1.75 min, HVST) had much shorter heating time. Compared to the samples of control (CT), there were a total of 213 differential metabolites identified, among them, 73, 78, and 62 were presented in HVST, LVLT, and WB samples, revealing a stronger metabolomic response of E. coli cells to HVST and LVLT than WB. KEGG enrichment analysis indicated that the significantly enriched pathways were biosynthesis and metabolism of amino acids (alanine, arginine, aspartate, and glutamate, etc.), followed by aminoacyl-tRNA biosynthesis among the three treatments. This is the first metabolomic study of E. coli cells in response to ohmic heating and presents an important step toward understanding the mechanism of ohmic heating on microbial inactivation, and can serve as a theoretical basis for better application of ohmic heating in food products.Entities:
Keywords: HPLC-MS/MS; amino acid metabolism; lipid metabolism; sublethal injury; untargeted metabolomic analysis
Year: 2018 PMID: 30574129 PMCID: PMC6291463 DOI: 10.3389/fmicb.2018.02936
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Inactivation of E. coli O157:H7 cells by HVST, LVLT, and WB treatments.
| Treatments | Time (min) | Temperature (°C) | Plate counts (log CFU/mL) | Sublethal ratio (%) | ||
|---|---|---|---|---|---|---|
| TSA | TAL | IMSA | ||||
| CT | 8.24 ± 0.13b | 8.16 ± 0.08b | 8.07 ± 0.11b | |||
| HVST | 1.75 | 57.90 ± 0.20a | 6.81 ± 0.07a | 6.46 ± 0.06a | 5.57 ± 0.07a | 84.11 ± 0.50a |
| LVLT | 8.50 | 58.60 ± 0.51ab | 6.83 ± 0.07a | 6.40 ± 0.14a | 5.60 ± 0.04a | 80.50 ± 3.10a |
| WB | 5.50 | 59.50 ± 0.70b | 6.81 ± 0.06a | 6.48 ± 0.06a | 5.58 ± 0.03a | 83.07 ± 1.87a |
FIGURE 1Principal component analysis (PCA) of metabolites from CT, HVST, LVLT, and WB-treated E. coli O157:H7 cells. t[1] was the first principal component, and t[2] was the second principal component.
FIGURE 2OPLS-DA modeling of metabolites from E. coli O157:H7 cells. S-plots (A–C) showed the analysis of datasets for HVST vs. CT, LVLT vs. CT, and WB vs. CT treated samples, respectively. t[1] was the first principal component (predicted principal component), and to[1] was the second principal component (orthogonal principal component). (D–F) Permutation testing confirmed the good quality of each model.
List of differential metabolites from HVST vs. CT, LVLT vs. CT, and WB vs. CT treated E. coli O157:H7 cells.
| Metabolites | Retention time (min) | m/z | Ion mode | HVST vs. CT | LVLT vs. CT | WB vs. CT | |||
|---|---|---|---|---|---|---|---|---|---|
| VIP | Trend | VIP | Trend | VIP | Trend | ||||
| Arachidic acid | 8.79 | 335.2928 | POS | 1.72 | ↑ | 2.60 | ↑ | ||
| Arachidonic acid | 6.85 | 339.1996 | NEG | 2.29 | ↑ | 3.55 | ↑ | ||
| CPA(18:0/0:0) | 9.55 | 421.2694 | POS | 1.21 | ↑ | ||||
| D-Glycerate 3-phosphate | 0.76 | 184.9859 | NEG | 1.43 | ↑ | 2.08 | ↑ | ||
| LysoPC(14:1(9Z)) | 6.99 | 466.2905 | POS | 11.61 | ↑ | 12.89 | ↑ | ||
| LysoPC(14:1(9Z)) | 6.85 | 464.2778 | NEG | 6.81 | ↑ | 5.07 | ↑ | ||
| LysoPC(15:0) | 8.48 | 482.3221 | POS | 2.93 | ↑ | 3.47 | ? | ||
| LysoPC(15:0) | 8.23 | 480.3090 | NEG | 1.73 | ↑ | 1.56 | ↑ | 1.45 | ↑ |
| LysoPE(0:0/14:0) | 6.16 | 426.2595 | POS | 7.90 | ↑ | 8.31 | ↑ | ||
| LysoPE(0:0/14:0) | 6.16 | 424.2466 | NEG | 4.46 | ↑ | 3.30 | ↑ | ||
| LysoPE(0:0/14:1(9Z)) | 5.77 | 422.2309 | NEG | 1.13 | ↑ | ||||
| LysoPE(0:0/14:1(9Z)) | 5.66 | 424.2439 | POS | 2.02 | ↑ | 1.27 | ↓ | 2.58 | ↑ |
| LysoPE(0:0/15:0) | 6.63 | 440.2751 | POS | 8.39 | ↑ | 3.51 | ↑ | 8.45 | ↑ |
| LysoPE(0:0/15:0) | 6.58 | 438.2622 | NEG | 4.37 | ↑ | 1.69 | ↑ | 3.25 | ↑ |
| LysoPE(0:0/16:0) | 6.94 | 454.2907 | POS | 6.97 | ↑ | 4.49 | ↑ | 6.57 | ↑ |
| LysoPE(0:0/16:0) | 7.05 | 452.2779 | NEG | 10.95 | ↑ | 7.62 | ↑ | ||
| Myristic acid | 11.72 | 227.2017 | NEG | 3.07 | ↑ | ||||
| PE(14:0/18:3(6Z,9Z,12Z)) | 12.78 | 684.4601 | NEG | 1.36 | ↑ | ||||
| PE(14:1(9Z)/15:0) | 13.06 | 646.4447 | NEG | 2.48 | ↑ | ||||
| Sphinganine | 6.94 | 302.3036 | POS | 1.14 | ↓ | 10.56 | ↑ | ||
| Argininosuccinic acid | 3.23 | 291.1439 | POS | 2.34 | ↓ | ||||
| D-Ala-D-Ala | 0.66 | 161.0914 | POS | 5.22 | ↓ | 4.11 | ↓ | 4.40 | ↓ |
| D-Ala-D-Ala | 0.85 | 159.0778 | NEG | 3.50 | ↓ | 3.08 | ↓ | 2.90 | ↓ |
| Glutathione | 0.73 | 306.0766 | NEG | 1.24 | ↓ | 1.17 | ↓ | 1.11 | ↓ |
| Indole | 2.47 | 118.0646 | POS | 2.83 | ↑ | ||||
| Ketoleucine | 2.08 | 129.0559 | NEG | 1.18 | ↑ | ||||
| L-Arginine | 0.94 | 173.1047 | NEG | 1.13 | ↓ | 1.07 | ↓ | ||
| L-Arginine | 0.59 | 175.1183 | POS | 1.60 | ↓ | 1.41 | ↓ | 1.30 | ↓ |
| L-Asparagine | 2.47 | 155.0444 | POS | 1.02 | ↑ | ||||
| L-Glutamate | 0.66 | 148.0598 | POS | 4.64 | ↓ | 4.43 | ↓ | 3.84 | ↓ |
| L-Glutamate | 1.21 | 130.0876 | NEG | 2.07 | ↓ | 2.25 | ↓ | 2.14 | ↓ |
| L-Glutamine | 0.63 | 169.0586 | POS | 1.02 | ↓ | 1.12 | ↓ | ||
| L-Histidine | 0.58 | 156.0761 | POS | 1.07 | ↓ | ||||
| L-Isoleucine | 1.18 | 132.1014 | POS | 9.47 | ↓ | 10.12 | ↓ | 7.69 | ↓ |
| L-Isoleucine | 1.71 | 164.0719 | NEG | 2.74 | ↓ | 2.88 | ↓ | 1.68 | ↓ |
| L-Lysine | 0.60 | 169.0941 | POS | 1.25 | ↓ | ||||
| L-Lysine | 0.94 | 145.0986 | NEG | 1.14 | ↓ | 1.03 | ↓ | ||
| L-Methionine | 0.69 | 150.0576 | POS | 2.78 | ↓ | 2.62 | ↓ | 2.28 | ↓ |
| L-Methionine | 0.80 | 146.0462 | NEG | 2.58 | ↓ | 2.54 | ↓ | ||
| L-Methionine | 0.93 | 148.0441 | NEG | 1.31 | ↓ | ||||
| L-Phenylalanine | 1.61 | 166.0856 | POS | 10.42 | ↓ | 10.33 | ↓ | 8.54 | ↓ |
| L-Phenylalanine | 0.93 | 148.0441 | NEG | 1.51 | ↓ | 1.53 | ↓ | 2.25 | ↓ |
| L-Proline | 0.66 | 116.0701 | POS | 2.68 | ↓ | 2.17 | ↓ | ||
| L-Tryptophan | 2.38 | 205.0963 | POS | 1.89 | ↓ | 1.73 | ↓ | 1.56 | ↓ |
| L-Tyrosine | 0.90 | 182.0805 | POS | 2.72 | ↓ | 2.51 | ↓ | 2.22 | ↓ |
| L-Valine | 0.90 | 116.0721 | NEG | 1.15 | ↓ | 1.22 | ↓ | ||
| L-Valine | 0.86 | 118.0858 | POS | 3.14 | ↓ | 3.21 | ↓ | 2.54 | ↓ |
| Ornithine | 1.12 | 155.0809 | POS | 1.71 | ↓ | 2.13 | ↓ | 1.25 | ↓ |
| β-Alanine | 0.66 | 90.0544 | POS | 2.15 | ↓ | 1.82 | ↓ | ||
| γ-Aminobutryic acid | 0.63 | 126.0521 | POS | 1.28 | ↓ | 1.49 | ↓ | ||
| Adenine | 0.66 | 136.0612 | POS | 8.59 | ↑ | 11.40 | ↑ | 7.72 | ↑ |
| Adenine | 1.22 | 170.0241 | NEG | 1.20 | ↑ | 1.40 | ↑ | ||
| Adenosine | 0.86 | 268.1030 | POS | 1.10 | ↓ | 1.11 | ↓ | ||
| Adenosine | 1.71 | 302.0661 | NEG | 1.04 | ↑ | ||||
| Adenosine | 0.73 | 505.9882 | NEG | 2.96 | ↑ | ||||
| cAMP | 1.22 | 328.0450 | NEG | 2.06 | ↑ | 1.76 | ↓ | 1.47 | ↑ |
| ADP | 0.77 | 426.0221 | NEG | 4.21 | ↑ | ||||
| ADP | 0.89 | 428.0355 | POS | 1.23 | ↑ | ||||
| ATP | 1.22 | 328.0450 | NEG | 2.33 | ? | ||||
| Cytosine | 0.66 | 112.0501 | POS | 1.37 | ↑ | ||||
| 5′-CMP | 0.77 | 322.0447 | NEG | 1.14 | ↑ | ||||
| CTP | 0.73 | 481.9766 | NEG | 1.04 | ↑ | ||||
| Guanine | 0.86 | 152.0560 | POS | 1.14 | ↑ | ||||
| cGMP | 0.86 | 346.0533 | POS | 1.06 | ↑ | 1.19 | ↑ | 1.06 | ↑ |
| cGMP | 0.89 | 344.0401 | NEG | 1.19 | ↑ | 1.41 | ↑ | ||
| dGMP | 0.84 | 348.0691 | POS | 1.07 | ↑ | 2.19 | ↑ | 1.15 | ↑ |
| dGMP | 0.85 | 346.0557 | NEG | 1.37 | ↑ | 1.18 | ↑ | ||
| dGMP | 0.86 | 268.1030 | POS | 1.74 | ↑ | ||||
| Hypoxanthine | 0.86 | 137.0452 | POS | 5.93 | ↓ | 5.87 | ↓ | ||
| Hypoxanthine | 0.90 | 135.0316 | NEG | 1.61 | ↓ | 1.09 | ↓ | 1.48 | ↓ |
| Inosine | 0.90 | 291.0688 | POS | 1.34 | ↓ | ||||
| Inosine | 0.79 | 323.0287 | NEG | 1.82 | ↑ | 1.53 | ↓ | ||
| Uracil | 0.67 | 113.0340 | POS | 1.79 | ↓ | 1.98 | ↑ | 1.68 | ↓ |
| Uracil | 0.91 | 111.0203 | NEG | 4.19 | ↓ | 3.84 | ↓ | ||
| UMP | 2.48 | 784.1488 | NEG | 2.85 | ↓ | ||||
| UDP | 0.76 | 402.9948 | NEG | 2.40 | ↑ | ||||
| Thymine | 1.03 | 127.0497 | POS | 1.27 | ↓ | 1.28 | ↓ | 1.04 | ↓ |
| Flavin adenine dinucleotide | 2.48 | 784.1488 | NEG | 2.90 | ↓ | 3.07 | ↑ | 2.40 | ↓ |
| Flavine mononucleotide | 2.69 | 457.1104 | POS | 1.12 | ↓ | 1.49 | ↓ | ||
| Flavine mononucleotide | 2.68 | 455.0969 | NEG | 1.16 | ↓ | ||||
| Xanthine | 1.17 | 151.0264 | NEG | 1.62 | ↓ | 1.42 | ↓ | ||
| Xanthosine | 2.71 | 285.0970 | POS | 1.05 | ↓ | 1.25 | ↓ | 1.10 | ↓ |
| Citric acid | 0.73 | 191.0200 | NEG | 1.33 | ↑ | 2.48 | ↑ | ||
| Malic acid | 0.80 | 133.0146 | NEG | 2.13 | ↓ | 1.92 | ↑ | 1.97 | ↓ |
| Succinic acid | 0.77 | 117.0197 | NEG | 7.50 | ↓ | 8.24 | ↓ | 6.08 | ↓ |
| Lactic acid | 13.95 | 124.9996 | NEG | 1.24 | ↓ | ||||
| D-Ribulose | 0.63 | 173.0413 | POS | 1.39 | ↑ | 1.04 | ↑ | ||
| L-Rhamnulose | 0.62 | 187.0621 | POS | 1.18 | ↓ | 1.00 | ↓ | ||
| UDP-glucose | 0.76 | 565.0477 | NEG | 4.46 | ↓ | 4.42 | ↓ | 4.37 | ↓ |
| α-ketoisovaleric acid | 2.47 | 117.0568 | POS | 1.25 | ↑ | ||||
| cAMP | 1.22 | 328.0450 | NEG | 2.06 | ↑ | 1.76 | ↓ | 1.47 | ↑ |
| ADP | 0.77 | 426.0221 | NEG | 4.21 | ↑ | ||||
| ADP | 0.89 | 428.0355 | POS | 1.23 | ↑ | ||||
| ATP | 1.22 | 328.0450 | NEG | 2.33 | ? | ||||
| Inosine | 0.90 | 291.0688 | POS | 1.51 | ↓ | 1.08 | ↓ | ||
| Flavin adenine dinucleotide | 2.48 | 784.1488 | NEG | 2.90 | ↓ | 3.07 | ↑ | 2.40 | ↓ |
| Flavine mononucleotide | 2.69 | 457.1104 | POS | 1.12 | ↓ | 1.49 | ↓ | ||
| Flavine mononucleotide | 2.68 | 455.0969 | NEG | 1.16 | ↓ | ||||
| Niacin | 0.70 | 124.0388 | POS | 1.80 | ↓ | 2.04 | ↓ | 1.44 | ↓ |
| Niacinamide | 0.66 | 123.0548 | POS | 6.63 | ↓ | 5.88 | ↓ | 6.21 | ↓ |
| Pantothenic acid | 1.71 | 220.1171 | POS | 5.94 | ↓ | 6.59 | ↓ | ||
| Pantothenic acid | 1.17 | 218.1036 | NEG | 1.90 | ↓ | 2.12 | ↓ | ||
FIGURE 3KEGG pathway enrichment analysis of differentially expressed metabolites from E. coli O157:H7 cells. (A–C) Showed the analysis for HVST vs. CT, LVLT vs. CT, and WB vs. CT treated samples, respectively. ∗ represented P < 0.05, ∗∗ represented P < 0.01, and ∗∗∗ represented P < 0.001.